LaMar Price II was selected as one of 100 high school students from across the U.S. awarded for their passionate essays detailing the need to find a cure for cancer
Recipients of awards made possible by grants from Genentech, Bristol-Myers Squibb and Novartis
DETROIT, MI, FEBRUARY 9, 2018 – Today, LaMar Price II from University of Detroit Jesuit High School and Academy was announced as one of 100 award recipients for the third year of PBS's and Stand Up To Cancer's Emperor Science Award program. The program is designed to empower high school students to become the next generation of scientists as they explore careers in cancer research and care through a unique mentoring opportunity. Three of the Awardees are students receiving support for a second year of mentorship, as allowed by the program.
PBS and Stand Up To Cancer, a division of the Entertainment Industry Foundation, received nearly 600 applications from eligible 10th and 11th grade students in 28 states throughout the U.S. who are interested in pursuing a career in science research. Prominent scientists served as judges and evaluated the students' applications: written essays submitted online this fall, addressing how cancer has affected them or their communities; how science can help find a cure for cancer; and, if they are able to become cancer researchers, what scientific fields would they study and why.
"University of Detroit Jesuit High School and Academy is proud to recognize LaMar Price II as an Emperor Science Award recipient. LaMar Price II was chosen from a pool of hundreds of 10th and 11th grade students from across the country that are interested in pursuing a career in science and cancer research," said University of Detroit Jesuit and Academy Principal Anthony Trudel. "Lamar Price II will represent University of Detroit Jesuit High School and Academy and the entire Detroit community as he continues to enhance his knowledge and skills through this one-of-a-kind mentorship program."
The 100 Emperor Science Award recipients will work with an esteemed university scientist on a rewarding multi-week cancer research project, receive a Google Chromebook computer to enhance their studies and to facilitate mentor access for those students who live at a distance from their mentor's research facility, and a $1,500 stipend for expenses. Those entering the program for the first year will also have the opportunity to apply for a second year.
Students from rural, suburban and urban communities in 28 states comprise the third class of Emperor Science Awardees. These students demonstrated awareness of emerging developments in cancer treatment, including precision medicine, immunotherapy and epigenetics, and have an impressive range of research focuses and interests, including nanotechnology and engineering, basic cellular biology, gene mapping, bioinformatics, DNA splicing and computational sciences.
LaMar Price II is a sophomore at University of Detroit Jesuit High School and Academy. He is a member of the school's baseball, soccer and basketball teams. He is also a captain of the chess team, an editor for INSCAPE (school literary arts magazine) and member of BASE (Black Awareness Society for Education). He has aspirations of conducting medical research and playing Division 1 college baseball.
The Emperor Science Award Program extends the learning and outreach for the PBS documentary, Ken Burns Presents CANCER: THE EMPEROR OF ALL MALADIES A Film by Barak Goodman.
The Emperor Science Award Program has been made possible by generous financial support from Founding Donors Genentech, a member of the Roche Group, Bristol-Myers Squibb Company and Novartis. Their support will fund a total of 300 awards through the first three years.
About University of Detroit Jesuit High School and Academy:
University of Detroit Jesuit is Detroit's second oldest high school. Founded in 1877, it has educated young men to be – "Men for Others" – through academic excellence, faith formation, and community service for 141 years. It remains Metro Detroit's most ethnically, geographically, and culturally diverse high school. 918 students are enrolled in grades seven through twelve from more than seventy communities in six counties. More than one-third of the students qualify for tuition assistance totaling $2.2 million annually.
About Stand Up To Cancer
Stand Up To Cancer (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C, a division of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, was established in 2008 by film and media leaders who utilize the industry's resources to engage the public in supporting a new, collaborative model of cancer research, and to increase awareness about cancer prevention as well as progress being made in the fight against the disease. As SU2C's scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee led by Nobel Laureate Phillip A. Sharp, PhD, conduct rigorous, competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.
Current members of the SU2C Council of Founders and Advisors (CFA) include Katie Couric, Sherry Lansing, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, Ellen Ziffren, and Kathleen Lobb. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Sung Poblete, PhD, RN, has served as SU2C's president since 2011.
PBS, with nearly 350 member stations, offers all Americans the opportunity to explore new ideas and new worlds through television and digital content. Each month, PBS reaches nearly 100 million people through television and nearly 28 million people online, inviting them to experience the worlds of science, history, nature and public affairs; to hear diverse viewpoints; and to take front row seats to world-class drama and performances. PBS' broad array of programs has been consistently honored by the industry's most coveted award competitions. Teachers of children from pre-K through 12th grade turn to PBS for digital content and services that help bring classroom lessons to life. Decades of research confirms that PBS' premier children's media service, PBS KIDS, helps children build critical literacy, math and social-emotional skills, enabling them to find success in school and life. Delivered through member stations, PBS KIDS offers high-quality educational content on TV – including a new 24/7 channel, online at pbskids.org, via an array of mobile apps and in communities across America. More information about PBS is available at www.pbs.org, one of the leading dot-org websites on the internet, or by following PBS on Twitter, Facebook or through our apps for mobile and connected devices. Specific program information and updates for press are available at pbs.org/pressroom or by following PBS Pressroom on Twitter.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, cost-saving generic and biosimilar pharmaceuticals and eye care. Novartis has leading positions globally in each of these areas. In 2017, the Group achieved net sales of USD 49.1 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion. Novartis Group companies employ approximately 122,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world. For more information, please visit http://www.novartis.com.
Vice President for Institutional Advancement
U of D Jesuit High School and Academy